RECRUITING

Promoting Resilience in Early Survivorship Among Adolescents and Young Adults With Cancer

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this study is to find the best way to help participants and families manage the stress of facing a serious illness and be better able to "bounce back" or be resilient after a difficult situation. Participants will take part in the "Promoting Resilience in Stress Management" PRISM program, which is designed to provide skills to change or improve the impact of stress in everyday life. The name of the intervention used in this research study is: -PRISM (a mobile app program comprised of 6 sessions of skills-based, manualized resilience education)

Official Title

Promoting Resilience in Early Survivorship Among Adolescents and Young Adults With Cancer

Quick Facts

Study Start:2023-10-16
Study Completion:2026-09
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06038318

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:12 Years to 25 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. * All genders ≥ 12 and ≤ 25 years of age at baseline
  2. * Participant is able to speak English or Spanish language (for PRISM sessions)
  3. * Participant is able to read English or Spanish language (for completion of surveys)
  4. * Participant is cognitively able to participate in PRISM sessions and complete written questionnaires and surveys, as judged by the site investigator
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Abby Rosenberg, MD
CONTACT
206-987-6892
AbbyR_Rosenberg@DFCI.HARVARD.EDU

Principal Investigator

Abby Rosenberg, MD
PRINCIPAL_INVESTIGATOR
Dana-Farber Cancer Institute

Study Locations (Sites)

Boston Children's Hospital
Boston, Massachusetts, 02215
United States
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215
United States

Collaborators and Investigators

Sponsor: Dana-Farber Cancer Institute

  • Abby Rosenberg, MD, PRINCIPAL_INVESTIGATOR, Dana-Farber Cancer Institute

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-10-16
Study Completion Date2026-09

Study Record Updates

Study Start Date2023-10-16
Study Completion Date2026-09

Terms related to this study

Keywords Provided by Researchers

  • Stress Management

Additional Relevant MeSH Terms

  • Stress
  • Anxiety